Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Aobang Good Pharmaceutical is a comprehensive pharmaceutical enterprise based in Chengdu, China, specializing in the research, development, and large-scale manufacturing of chemical drug products. As a key subsidiary of the Aobang Pharmaceutical Group, the company operates high-standard production lines for injections, tablets, and capsules, all compliant with national GMP certifications. Its core therapeutic focus includes gastroenterology, cardiovascular diseases, and anti-infective treatments, with a strong portfolio of proton pump inhibitors and antibiotics. The company integrates R&D with commercial manufacturing to provide high-quality generic medications and is increasingly investing in innovative drug development. Located within the Chengdu Medical City, Aobang Good Pharmaceutical leverages regional industrial clusters to enhance its supply chain and technical capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 四川奥邦古得药业.